setmelanotide Injectable solution bulk supplier for pharma manufacturers

Setmelanotide Injectable Solution 4 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 4 mg/mL

Reference Brands: Imcivree(Us & EU)

Setmelanotide is a melanocortin-4 receptor agonist that regulates appetite and energy balance. It helps reduce hunger, support weight loss, and improve metabolic health in patients with rare genetic obesity syndromes. Benefits include appetite suppression, increased energy expenditure, and improved quality of life for affected individuals worldwide.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Setmelanotide Injectable Solution? List it or send an offer →

Product Description: Setmelanotide injectable solution, marketed as Imcivree, is approved in the US by the FDA and in the EU via EMA for treating obesity caused by rare genetic disorders such as POMC deficiency, PCSK1 deficiency, and Bardet-Biedl syndrome. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. Proper adherence supports swift approval, safe administration, and global availability to help patients worldwide manage rare genetic obesity effectively.

Setmelanotide Injectable Solution — third party manufacturing & bulk supply

Setmelanotide Injectable Solution 4 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Setmelanotide Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Setmelanotide Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Setmelanotide Injectable Solution →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

setmelanotide Injectable solution is listed as Injectable Solution in 4 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

setmelanotide Injectable solution is referenced against Imcivree(Us & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.